Started By
Message

re: Afrezza and MNKD

Posted on 4/7/14 at 8:12 am to
Posted by donRANDOMnumbers
Hub City
Member since Nov 2006
16960 posts
Posted on 4/7/14 at 8:12 am to
Aaaaand FDA not folding that easy. Extended review for 3 more months to do more in depth research.

FDA really doesn't want to do this one. Will see 20% or so sell off today IMO.
This post was edited on 4/7/14 at 8:13 am
Posted by jb4
Member since Apr 2013
12723 posts
Posted on 4/7/14 at 9:57 am to
yeap, this is really an episode of house of cards corruption style. FDA bigwigs probably thought the panel would vote no or much closer. What is the real tell and had me confused was the lack of bounce post panel vote. I though it would jump much higher. Now they got 3 months to F things up for MNKD but i still don't see how it doesn't' get passed. Why the hate for MNKD by the FDA. For starters, the FDA head husband runs a big bio tech fund, lots of shorts in MNKD. Than throw in big pharm who throw around lots of donations doesn't want to lose money to the upstart therapy. If you can't beat join them, MNKD probably sells out, so i like the buy.
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram